Public disclosure of the August 2026 monthly exercise status for the 13th stock acquisition right (with exercise price adjustment clause). Exercised shares: 0 shares; exercise rate against total issued: 0.00%; unexercised rights: 8,338 units; issued shares: 57,559,412 shares (treasury shares: 11,387).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4576","jir_company_name":"De Westin Therapitechs Institute","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4576-20260901-01.pdf","jir_short_summary":"Public disclosure of the August 2026 monthly exercise status for the 13th stock acquisition right (with exercise price adjustment clause). Exercised shares: 0 shares; exercise rate against total issued: 0.00%; unexercised rights: 8,338 units; issued shares: 57,559,412 shares (treasury shares: 11,387).","jir_summary":"### Background and exercise status\nThis report summarizes the August 2026 monthly exercise status of the 13th stock acquisition right (with exercise price adjustment clause) issued on July 31, 2025. The number of shares delivered for the target month is 0 shares, the number of stock acquisition rights exercised is 0, with an exercise ratio of 0.000%. Unexercised stock acquisition rights for the target month total 8,338, and the compliance with exercise restrictions regarding the issued shares is 0%.\n\n### Share count and potential impact going forward\nTotal issued shares are 57,559,412, of which 11,387 are treasury shares. There were no actual exercises in the current month, and unexercised stock acquisition rights continue to exist. Indicators related to exercise restrictions are not applicable, and the company\u2019s stock option policies remain unchanged. The potential market impact going forward is undetermined; timing and figures of any exercise will be disclosed in the next report.","jir_financial_highlights":"Number of unexercised stock acquisition rights: 8,338 units (Same as end of prior month)\nNumber of stock acquisition rights exercised in the relevant month: 0 units (0.00% exercise rate (against total issued))\nTotal issued shares: 57,559,412 shares (of which treasury shares 11,387 shares)","jir_category":"","jir_hashtags":"#StockAcquisitionRights","jir_key_figures":"Number of unexercised stock acquisition rights: 8,338 units\nNumber of exercised stock acquisition rights: 0 units\nTotal issued: 57,559,412 shares (including 11,387 treasury shares)","jir_meta_title":"\u3010De Westin Therapitechs Institute\u3011Stock Acquisition Right Exercise Status (Monthly)\uff5cAugust 2026","jir_meta_description":"De Westin Therapitechs Institute announces the monthly exercise status of the 13th stock acquisition right. August: 0 exercises, unexercised 8,338 units, total issued shares 57,559,412, treasury shares 11,387. Focus on future exercise developments.","jir_og_title":"\u3010De Westin Therapitechs Institute\u3011Stock Acquisition Right Monthly Exercise Status\uff5cAugust 2026","jir_og_description":"Public release of the August monthly exercise status for the 13th stock acquisition right. Exercised: zero; unexercised: 8,338 units; total issued shares: 57,559,412; treasury shares: 11,387. Look out for next update.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59943,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-109560","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n